147 related articles for article (PubMed ID: 6213193)
1. In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
Azimi PH; Dunphy MG
Antimicrob Agents Chemother; 1982 Mar; 21(3):521-4. PubMed ID: 6213193
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Tarpay MM; Welch DF; Marks MI
Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
McCracken GH; Nelson JD; Grimm L
Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
Fernández-Roblas R; López JC; Ramos JM; Gimeno M; Coronel P; Soriano F
J Antimicrob Chemother; 1996 May; 37(5):1038-9. PubMed ID: 8737159
[No Abstract] [Full Text] [Related]
6. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Landesman SH; Corrado ML; Cherubin CE; Sierra MF
Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
[TBL] [Abstract][Full Text] [Related]
7. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
Chu ML; Harms JL; Liu C
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
[TBL] [Abstract][Full Text] [Related]
10. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
Bergeron MG; Claveau S; Simard P
Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.
Mason EO; Kaplan SL; Anderson DC; Hinds DB; Feigin RD
Antimicrob Agents Chemother; 1980 Mar; 17(3):470-3. PubMed ID: 6448579
[TBL] [Abstract][Full Text] [Related]
13. [Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics].
Guggenbichler JP
Padiatr Padol; 1983; 18(1):11-20. PubMed ID: 6403908
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
Fass RJ
Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of six beta-lactam antibiotics against strains of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae.
Soares LA; Melles CE
Infection; 1982; 10 Suppl 3():S234-7. PubMed ID: 6818156
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Goto S
Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
19. Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis.
Soriano F; Coronel P; Gimeno M; Jiménez M; García-Corbeira P; Fernández-Roblas R
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):761-3. PubMed ID: 8922582
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility of type b Haemophilus influenzae and Streptococcus pneumoniae, and antibiotic concentration in cerebrospinal fluid.
Fujita K; Zhang DH; Sakata H; Murono K; Kakehashi H; Yoshioka H
Acta Paediatr Jpn; 1990 Apr; 32(2):132-8. PubMed ID: 2116062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
